Koç, O N <br/><br/>
DeltaMGMT-transduced bone marrow infusion increases tolerance to O6-benzylguanine and 1,3-bis(2-chloroethyl)-1-nitrosourea and allows intensive therapy of 1,3-bis(2-chloroethyl)-1-nitrosourea-resistant human colon cancer xenografts.  [electronic resource] 

 -  Human gene therapy  Apr 1999 
 - 1021-30 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>1043-0342 
<br/><br/><label>Standard No.: </label>10.1089/10430349950018418  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents, Alkylating--pharmacology<br/>Bone Marrow Transplantation<br/>Carmustine--pharmacology<br/>Cell Division--drug effects<br/>Colonic Neoplasms--drug therapy<br/>Combined Modality Therapy<br/>Drug Resistance, Neoplasm<br/>Genetic Vectors<br/>Guanine--analogs & derivatives<br/>Humans<br/>Mice<br/>Mice, Nude<br/>Neoplasm Transplantation<br/>O(6)-Methylguanine-DNA Methyltransferase--genetics<br/>Retroviridae--genetics<br/>Transduction, Genetic